What would Halsted say! @TGen @MayoClinic @CRUK_CI @cityofhope @ZainHashmiMD @NabeelZafarMD @MustafaRaoofMD
RT @UroDocAsh: Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer https://t.…
Interesting read : Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer | Science Translational Medicine https://t.co/UoCSrPqoR2
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @jesusanampa: Targeted digital sequencing (TARDIS), using ctDNA customized for each patient, can be used to monitor the patient over t…
RT @DraAnaCasas: ctDNA tracking could enable individualized clinical management of patients w/cancer treated with curative intent. @_SOLTI…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer https://t.co/YF6sqILyb0
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @montypal: Exciting news coming out of @TGen, a @cityofhope affiliate. @TDorffOnc doing work w this platform in #ProstateCancer - excite…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @montypal: Exciting news coming out of @TGen, a @cityofhope affiliate. @TDorffOnc doing work w this platform in #ProstateCancer - excite…
RT @ZainHashmiMD: Another fantastic breakthrough by @MurtazaMDPhD lab to move the field forward! Congratulations! “Personalized circulati…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
@RobClarkeLab
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
@TGen The study was published in Science Translational Medicine and done in collaboration with researchers from City of Hope, UK Cambridge Institute and Cancer Centre, Mayo Clinic and The Biodesign Institute at Arizona State University. https://t.co/XNopg1
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer https://t.co/u4kCfHkX3e
RT @jesusanampa: Targeted digital sequencing (TARDIS), using ctDNA customized for each patient, can be used to monitor the patient over t…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @_SOLTI: Últimos avances en biopsia líquida 😮 El prometedor futuro de la clasificación de pacientes con #cáncerdemama Ponte al día de l…
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer https://t.co/VMlggbGCWL
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @jesusanampa: Targeted digital sequencing (TARDIS), using ctDNA customized for each patient, can be used to monitor the patient over t…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @BRMcDonald28: Very excited about our new paper on residual disease detection in early stage cancer using circulating tumor DNA. Lots o…
Congratulations @MurtazaMDPhD ! Exciting development! @AKUGlobal
RT @ZainHashmiMD: Another fantastic breakthrough by @MurtazaMDPhD lab to move the field forward! Congratulations! “Personalized circulati…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @sciencemagazine: Scientists have developed a personalized platform tailored to patients’ specific #cancer mutations named TARDIS, which…
RT @MustafaRaoofMD: This is transformative.. great to see this in print. Congrats @MurtazaMDPhD and team @tgen @cityofhope .. a blood test…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @EricTopol: @NatureBiotech @Cormac_Sheridan The field is moving so fast that there is another advance today for detecting residual disea…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @jesusanampa: Targeted digital sequencing (TARDIS), using ctDNA customized for each patient, can be used to monitor the patient over t…
Targeted digital sequencing (TARDIS), using ctDNA customized for each patient, can be used to monitor the patient over time and allow early detection of tumor recurrence after neoadjuvant therapy in #breastcancer #bcsm #OncoAlert @sciencemagazine https:
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
Amazing developement!
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @sciencemagazine: Scientists have developed a personalized platform tailored to patients’ specific #cancer mutations named TARDIS, which…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
Exciting news coming out of @TGen, a @cityofhope affiliate. @TDorffOnc doing work w this platform in #ProstateCancer - excited to see data in GU malignancies.
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer https://t.co/jSN7PBMI7h
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @_SOLTI: Últimos avances en biopsia líquida 😮 El prometedor futuro de la clasificación de pacientes con #cáncerdemama Ponte al día de l…
RT @Chris_G_Smith1: Great technique (TARDIS) and results from @MurtazaMDPhD and colleagues. Though disappointed that there's no mention of…
Great technique (TARDIS) and results from @MurtazaMDPhD and colleagues. Though disappointed that there's no mention of Dr Who... https://t.co/ZlHbyMWNRP https://t.co/6qnJUdIGgG
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
Incredible work by @TGen and collaborators @BRMcDonald28 @MayoClinic @CRUK_CI and @cityofhope - a personalised ctDNA analysis to detect residual disease in #breastcancer. Could be up to x 100 more sensitive than existing tests. Paper @ScienceTM 👉https://t.
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @_SOLTI: Últimos avances en biopsia líquida 😮 El prometedor futuro de la clasificación de pacientes con #cáncerdemama Ponte al día de l…
Últimos avances en biopsia líquida 😮 El prometedor futuro de la clasificación de pacientes con #cáncerdemama Ponte al día de los últimos avances en medicina de precisión en el #EnvisionSummit de @_SOLTI con el aval de @_SEOM INSCRIPCIONES ABIERTAS👉https:
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @prat_aleix: 2 estudios (https://t.co/u1Frfa1CtW https://t.co/FxNQvEO4XH) demuestran que la biopsia líquida en cáncer mama precoç tiene…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…
RT @prat_aleix: aunque existen ya tests comerciales para detectar ctDNA en este contexto, pido cautela. No deberían usarse sin tener claro…
RT @MurtazaMDPhD: our paper is now online @ScienceTM. Personalized ctDNA analysis to detect residual disease in breast cancer https://t.co/…